Well Buildit, As I stated before, there is surely a lot

New Post Public Reply Private Reply Replies (1) Message Board
Zolis_onkel Buildit #16966
413
Well Buildit,

As I stated before, there is surely a lot going on behind the scenes, but the fact is that the BARDA application is still not approved and as long as this is the case JoeM is simply NOT ALLOWED to talk about it.
And yes, it is truly interesting to recognize, as a previous poster pointed out correctly, how this silence brings the worst fears to the surface in most of us. But that is a very common reaction among most of us humans.
Let's make an experiment. From now on, and as long as we do not know better, we all only talk about the positive possibilities of how things will be working out perfectly well for GNBT and us shareholders, once BARDA has granted us a 3 digits millions of dollars amount!? So we simply expect the best possible outcome and do not even bother to worry about the negative "what-ifs".

In that sense, here is my positive, but realistic thought about what might be going on right now.:
Application with BARDA is running for more than 5 weeks now, so we are surely outside of that "immediate denial" window. That means BARDA is taking our application absolutely serious. GNBT is working deliberately on progressing their plan to develope a CV vaccine, which BARDA is aware of and thus knows that no time is lost to wait before the big funding is given to them, until the next big milestone in the development is reached, namely the successful in-vitro testing of and following selection of the vaccine candidate, which turned out to be the most promising one.
This may take another week or two before Joe/GNBT will receive the BARDA approval and until then they are not allowed to talk about it, in order not to risk an immediate denial by BARDA. Which is why they have to remain silent until then.
Does anybody really think that, after all the effort that GNBT has already put into the vaccine development and the application for BARDA funding, they would simply stop and not continue working on the vaccine? DEFINITELY NOT!
Why haven't we heard about any other stuff, like the S1s and subsequent uplisting, etc.?
Because the BARDA funding, that will be made available to GNBT, will make such a material difference to the company as a whole, that a reassessment of the company finances will become necessary. It will open up entirely new opportunities for the future of this company. So I am happy that they are currently not even thinking about touching the GNBT S1 funding and give away an unnecessary large amount of shares for a couple of million dollars just to make some further progress now, which could be falling into their laps without giving away cheap shares soon.
I still think that something, big, huge or even humongous is heading our way, and all we have to do is wait and continue to BELIEVE that it will be happening and we all will be golden.
BTW, docj, I will then change my username to "thanks-GNBT-for-my-financial-freedom" 8o)

May all of you have a wonderful Sunday, and we all get filthy rich with our GNBT investments.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 5

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 4

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 2

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

Dak Prescott Joins CR Fitness for Crunch Colleyville Launch Sale

Updated Category News Views 387

Dak Prescott Partners with CR Fitness for Exciting Launch Event CR Fitness Holdings, LLC, recognized as the fastest-growing franchise partner of Crunch Fitness, is thrilled to share an exclusive opportunity: a cyber sale to celebrate the grand opening of Crunch Colleyville, a state-of-the-art fitness facility. This brand-new gym, equipped with advanced features, will...

Continue Reading
Forex Market Faces Turmoil with Tariff Deadline Approaching

Updated Category News Views 155

Tariff Deadline and Its Implications on Forex Trading The forex market is currently navigating through a challenging landscape as a significant tariff deadline approaches. Market participants are closely watching the developments as key figures in the central banking world converge on Europe, particularly during the recent forum held by the European Central Bank. Insights...

Continue Reading
Bemdaneprocel's Encouraging Outcomes for Parkinson’s Patients

Updated Category News Views 195

Bemdaneprocel’s journey through the clinical stage hit a high note back in 2024 with positive findings from its Phase 1 trial targeting Parkinson’s disease. This investigational cell therapy stirred some serious buzz after showing it could actually change lives for folks grappling with this neurodegenerative beast. Now, let’s unpack what went down. What's...

Continue Reading
KuCoin Secures AA Rating, Expands Commitment to User Safety

Updated Category News Views 151

KuCoin Receives Esteemed AAA Rating for Security KuCoin, a prominent global cryptocurrency exchange, has proudly secured a remarkable AAA rating on the cybersecurity platform CER.live. This prestigious recognition solidifies its standing as one of the most secure exchanges in the world. Such an achievement emphasizes the exchange's unyielding dedication to protecting its...

Continue Reading
Sprott Inc. Announces Exciting Second Quarter Dividend Details

Updated Category News Views 104

Sprott Inc. Declares New Dividend for Second Quarter 2025 Sprott Inc. is making headlines with a new announcement regarding its dividend for the second quarter of 2025. This declaration showcases the company's continued commitment to rewarding its shareholders. As a prominent asset manager specializing in precious metals and critical materials, Sprott is focused on...

Continue Reading